Curaderm

contains 0.005% solasodine glycoside; used to treat solar keratoses; no further information available 6/89

Networked: 1 relevant articles (1 outcomes, 1 trials/studies)

1.	Keratosis 09/01/1991 - "In an open study, clinical and histological observations indicated that all lesions (56 keratoses, 39 BCCs and 29 SCCs) treated with Curaderm had regressed. " 09/01/1991 - "We now report that a preparation (Curaderm) which contains very low concentrations of BEC (0.005%) is effective in the treatment of keratoses, basal cell carcinomas (BCCs) and squamous cell carcinomas (SCCs) of the skin of humans. "
2.	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/01/1991 - "We now report that a preparation (Curaderm) which contains very low concentrations of BEC (0.005%) is effective in the treatment of keratoses, basal cell carcinomas (BCCs) and squamous cell carcinomas (SCCs) of the skin of humans. "
3.	Basal Cell Carcinoma (Rodent Ulcer) 09/01/1991 - "We now report that a preparation (Curaderm) which contains very low concentrations of BEC (0.005%) is effective in the treatment of keratoses, basal cell carcinomas (BCCs) and squamous cell carcinomas (SCCs) of the skin of humans. "